Search Results - "Chon, H.S."

Gene expression signature based prediction of lymph node metastasis in patients with endometrioid endometrial cancer by Chon, H.S, Kang, S, Lee, J.K, Gonzalez-Bosquet, J, Wenham, R.M, McClung, C, Abdallah, R

Get full text

Gene expression profiling of 389 endometrioid endometrial carcinomas reveals 4 distinct molecular subtypes by McClung, C, Berglund, A, Welsh, E.A, Xiong, Y, Bush, S.H, Robertson, S.E, Chon, H.S, Magliocco, A, Marchion, D, Apte, S.M

Get full text

Inbound referral patterns for ovarian cancer patients at a National Comprehensive Cancer Network (NCCN) institution by Khulpateea, B.R, Boac, B.M, Xiong, Y, Shahzad, M.M.K, Wenham, R.M, Apte, S.M, Munroe, D.G, Chon, H.S

Get full text

The impact of depression on survival in uterine carcinosarcoma by Bush, S.H, Whynott, R.M, Abdallah, R, Xiong, Y, Chon, H.S, Apte, S.M, Wenham, R.M, Judson, P, Lancaster, J.M, Shahzad, M.M.K

Get full text

Therapeutic dilemma: Prognostic factors and outcome for patients with neuroendocrine tumors of the cervix by Abdallah, R, Xiong, Y, Bush, S.H, Chon, H.S, Judson Lancaster, P.L, Wenham, R.M, Apte, S.M, Lancaster, J.M, Shahzad, M.M.K

Get full text

The BAD apoptotic pathway: A cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival by Bush, S.H, Marchion, D, Xiong, Y, Abbasi, F, Berry, A, Chon, H.S, Shahzad, M.M.K, Apte, S.M, Wenham, R.M, Judson, P, Lancaster, J.M

Get full text

Predictive value of CIRS severity index on survival in elderly women (>= 70 years) with advanced epithelial ovarian cancer by Song, Y.J., Todd, S.L., Xiong, Y., Wenham, R.M., Extermann, M., Chon, H.S.

Get full text

Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study by Ahmed, K.A., Quick, A.M., Bixel, K., Kim, Y., Lemerond, E., Chon, H.S., Chern, J.Y., Fernandez, D.C., Hoffman, M.S., Kim, S., Lam, C., Montejo, M.E., Shahzad, M.M., Wenham, R.M.

Get full text

Phase II study of durvalumab alone or in combination with ADXS11-001 (AXAL) in recurrent/persistent or metastatic cervical cancer by Slomovitz, B., Bradley, W.H., Ghamande, S., O'Malley, D.M., Huang, M., Chon, H.S., Vangala, S., Sheeri, S., Gutierrez, A.A., Moore, K.N.

Get full text

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy by Prince, A., Mohammadi, H., Fernandez, D.C., Montejo, M.E., Chon, H.S., Wenham, R.M., Eschrich, S.A., Torres-Roca, J.F., Ahmed, K.A.

Get full text

Utilizing Immune Profiles to Predict Pelvic Failure in Endometrial Cancer by Mohammadi, H., Prince, A., Kim, Y., Figura, N.B., Welsh, E., Fernandez, D.C., Montejo, M.E., Chon, H.S., Wenham, R.M., Eschrich, S.A., Torres-Roca, J.F., Grass, D., Ahmed, K.A.

Get full text

LBA41 Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva ± olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial by Westin, S.N., Moore, K.N., Chon, H.S., Lee, J-Y., Thomes Pepin, J., Sundborg, M., de la Garza, J., Nishio, S., Wang, K., Mcintyre, K., Tillmanns, T., Contreras Mejia, F., de Melo, A.C., Klasa-Mazurkiewicz, D., Papadimitriou, C.A., Gil Martín, M., Brasiuniene, B., Donnelly, C., Liu, X., Van Nieuwenhuysen, E.

Get full text

The impact of clinical trial participation on overall survival in advanced ovarian cancer patients at a single-institution cancer center by Mallen, A.R., Boac, B.M., Todd, S.L., Xiong, Y., Magliocco, A., Chon, H.S.

Get full text

Comparison of treatment and outcomes between medical oncology and gynecologic oncology as adjuvant chemotherapy provider in an advanced ovarian cancer population by Gandhi, A., Kuznicki, M., Mallen, A.R., Todd, S., Boac, B., Cao, B., Magliocco, A., Fridley, B., Wenham, R., Chon, H.S.

Get full text

883TiP MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer by Randall, L.M., O'Malley, D.M., Monk, B.J., Coleman, R.L., O'Cearbhaill, R.E., Gaillard, S., Adams, S., Cappuccini, F., Huang, M., Chon, H.S., Secord, A.A., Arora, S., Keeton, E., Gupta, D., Samnotra, V., Konstantinopoulos, P.

Get full text

Clinical Outcomes Following Adjuvant Management of FIGO Stage II Endometrial Cancer by Mohammadi, H., Abuodeh, Y.A., Naghavi, A.O., Fernandez, D.C., Montejo, M.E., Apte, S.M., Hoffman, M.S., Shahzad, M.M., Wenham, R.M., Chon, H.S., Ahmed, K.A.

Get full text

Clinical Outcome and Late Toxicity following Definitive Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma of the Vulva by Rishi, A., Rollins, M., Fernandez, D.C., Ahmed, K.A., Hoffman, M.S., Shahzad, M.M., Apte, S.M., Chern, J.Y., Chon, H.S., Wenham, R.M., Montejo, M.E.

Get full text

The Radiosensitivity of Cervical Cancer and its Influence on Patterns of Failure Following Definitive Concurrent Chemotherapy and Radiation by Yuan, Z.M., Abuodeh, Y.A., Fernandez, D.C., Montejo, M.E., Torres-Roca, J.F., Ahmed, K.A., Randolph, J., Shahzad, M.M., Chon, H.S., Wenham, R.M.

Get full text

40MO First-line (1L) durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib for endometrial cancer (EC) (DUO-E): Objective response rate (ORR), duration of response (DoR) and time to treatment discontinuation or death (TDT) by mismatch repair (MMR) status by Van Nieuwenhuysen, E., Chon, H.S., Pepin, J. Thomes, Sundborg, M., Gold, M., Kim, B-G., Blank, S.V., Liu, J., McCollum, M., Mori, M., Moore, K.N., Joseph de Pádua, C., Martinez-Garcia, J., Papadimitriou, C., Grisan, K., Póka, R.L., Donnelly, C., Liu, X., Westin, S.

Get full text

Worsening of ovarian cancer prognosis with age: an exploration of pharmacokinetics, body composition, and biology by Extermann, M., Walko, C., Mishra, A., Thomas, K., Cao, B., Chon, H.S., Critea, M., Berglund, A., Chem, J.Y., Cubitt, C., Gomes, A.P., Hoffman, M., Kim, J., Marchion, D., Petersson, F., Sansil, S., Sehovic, M., Shahzad, M., Welsh, E., Zhang, Y.

Get full text